MTCO2P30

Across TCGA pan-cancer cohorts, MTCO2P30 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTCO2P30’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MTCO2P30 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTCO2P30 is over-expressed in tumor, although a few such as BLCA and THCA show the opposite, repressed pattern.

STAD, BLCA, and THCA are the cancer types where MTCO2P30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCO2P30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.128	.025	4	view →
BLCA	Male	IV	−0.210	.036	1	view →
THCA	All	All	−0.061	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MTCO2P30–STAD

Open the STAD breakdown →